Iva Healthcare posts 35% growth in terms of sales

Iva Healthcare proudly declared 35% profits growth and got new approvals for Teneligliptin 20mg and Metformin Hydrochloride 500mg {SR}. Iva gave credits of success to their new marketing strategy, competent people and network. The company proudly posts 35% growth rates as compared to normal industry’s 14% CAGR in the last quarter.

The company has witnessed strong revenue and performance and is dedicatedly working to tap a new market and penetrate deeper into Indian Territory with its affordable and quality medicines.

The company experienced the healthy performance this year. Iva team is very dedicated to prioritizing new medical innovation with enhanced capabilities and improved efficiency, helping us to realize their marketing strategy, and driving their next phase of growth.

Iva healthcare is working hard to widening its horizons.This graph clearly explains how Ivs healthcare with their best planning and marketing strategy crossed the gross industry growth and recorded 35% growth in sales.

Iva Healthcare Private Limited is an India based company established in 2008. One of the best well-established pharma manufacturers, wholesaler, and traders. Company’s best products are Pharmaceutical Tablets, Azithromycin Tablets that are high-profit making products from an extensive range of products manufactured.

Iva has manufacturing collaboration with the reputed brand Theon Pharmaceutical Pvt., certified by world health organization for good manufacturing practices and international organization for standardization.

The company has made a special place in the market because of the quality medicines, owing to quick results, longer shelf life, and effectiveness.

Iva company keeps growing and constantly producing new, innovative and vigorous pharma products for all age groups to ensure the healthy living.

The company followed the guidelines and all production activities are taken in a clean and safe environment for the pharmacists and other employees. The company is working at their best levels just to ensure products should be harmless for all age groups and ensure quick and instant recovery.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre